Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii
Chao Liu1, Yaowen Chang1, Ying Xu2
1Non-coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China.
Abstract:
Acinetobacter baumannii is undoubtedly one of the most clinically significant pathogens. The multidrug resistance and virulence potential of A. baumannii are responsible for hospital-acquired nosocomial infections. Unlike numerous investigations on the drug-resistant epidemiology of A. baumanni, virulence molecular epidemiology is less studied. Here, we collected 88 A. baumannii clinical isolates, tested their antimicrobial susceptibility to 10 commonly used antibiotics and analyzed the distribution of 9 selected virulence-associated genes, aims to investigate the primary characteristics of the virulence-associated genes that exist in clinically multidrug resistant (MDR) and non-MDR isolates of A. baumannii. The MIC results showed the resistance rates of ciprofloxacin (68.2%, 60/88), gentamicin (67.0%, 59/88), amikacin (58.0%, 51/88), tobramycin (58.0%, 51/88), doxycycline (67.0%, 59/88), meropenem (54.5%, 48/88) and imipenem (65.9%, 58/88) were all above 50%, except for levofloxacin (34.1%, 30/88), minocycline (1.1%, 1/88) and polymyxin B (0%, 0/88). The Pulsed field gel electrophoresis (PFGE) analysis revealed that the resistance rate of MDR A. baumannii isolates in the Epidemic group was predominant (79.5%, 44/58), but in the Sporadic group was only 6.7% (2/30). Further investigation on the distribution of virulence genes showed the virulence genes bap (95.5%), surA1 (92.0%), BasD (92.0%), paaE (88.6%), pld (87.5%), BauA (62.5%), omp33-36 (59.1%) and pglC (53.4%) were accounted for high proportion, except for traT (0%). Overall, our results revealed that MDR isolates predominated in the Epidemic A. baumannii isolates, and contained a very high proportion of virulence genes, which may lead to high risk, high pathogenicity and high treatment challenge.
Insights
Multidrug-resistant Acinetobacter baumannii, a significant hospital pathogen, shows high prevalence of virulence genes in epidemic strains. These findings highlight the challenge in treating these infections.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Molecular Epidemiology
Background:
- Acinetobacter baumannii is a critical pathogen causing hospital-acquired infections.
- Multidrug resistance and virulence are key factors in its pathogenicity.
- The molecular epidemiology of virulence in A. baumannii is less understood than its drug resistance.
Purpose of the Study:
- To investigate the characteristics of virulence-associated genes in multidrug-resistant (MDR) and non-MDR Acinetobacter baumannii clinical isolates.
- To analyze the distribution of selected virulence genes in relation to antimicrobial resistance patterns.
Main Methods:
- Collected 88 Acinetobacter baumannii clinical isolates.
- Performed antimicrobial susceptibility testing against 10 common antibiotics.
- Analyzed the distribution of 9 selected virulence-associated genes.
- Utilized Pulsed Field Gel Electrophoresis (PFGE) to differentiate epidemic and sporadic isolates.
Main Results:
- High resistance rates (>50%) were observed for ciprofloxacin, gentamicin, amikacin, tobramycin, doxycycline, meropenem, and imipenem.
- Multidrug-resistant isolates predominated in the epidemic group (79.5%) compared to the sporadic group (6.7%).
- High proportions of virulence genes (e.g., bap, surA1, BasD) were found, particularly in MDR epidemic isolates.
Conclusions:
- MDR Acinetobacter baumannii isolates, especially epidemic strains, possess a high prevalence of virulence genes.
- The co-occurrence of multidrug resistance and virulence factors in epidemic isolates poses a significant clinical challenge.
- Further research is needed to understand the interplay between virulence and resistance in A. baumannii pathogenesis.
More Related Videos
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
08:37The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
Related Concept Videos
Antimicrobial Effectiveness
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Susceptibility, Permittivity and Dielectric Constant
Drug Distribution: Volume of Distribution
Gene Flow
